News from collegium pharmaceutical, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

May 31, 2013, 08:00 ET

Collegium Pharmaceutical's CEO to Present at the Jefferies 2013 Global Health Care Conference in New York on June 4, 2013

 Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, today announced that the Company's President and CEO, Michael Heffernan,...

May 17, 2013, 07:30 ET

Collegium Pharmaceutical's CEO to Present at the UBS Global Health Care Conference in New York on May 20, 2013

Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, today announced that the Company's President and CEO, Michael Heffernan, will...

May 08, 2013, 08:00 ET

Collegium Announces Poster Presentation for Oxycodone DETERx®, an Abuse-Deterrent, Extended-Release Opioid at American Pain Society's 32nd Annual Scientific Meeting

Collegium Pharmaceutical, Inc., a specialty pharmaceutical company focused on the development of innovative treatments for chronic pain, today...

Apr 30, 2013, 07:00 ET

Collegium Announces Results of Chronic Pain Patient Survey - Confirms Significant Unmet Medical Need for a Differentiated, Abuse-Deterrent, Extended-Release Opioid

 Collegium Pharmaceutical, Inc., a specialty pharmaceutical company focused on the development of innovative treatments for chronic pain, today...

Apr 22, 2013, 07:00 ET

Significant Unmet Medical Need for Treatment of Patients with Chronic Pain with Dysphagia (CPD)

 Collegium Pharmaceutical, Inc., a specialty pharmaceutical company focused on the development of innovative treatments for chronic pain, today...

Apr 17, 2013, 07:00 ET

Collegium Pharmaceutical Announces Successful Completion of Clinical Study Evaluating the Impact of Tampering on Oxycodone DETERx®, an Abuse-Deterrent, Extended-Release Opioid Product

Collegium Pharmaceutical, Inc., a specialty pharmaceutical company focused on the development of innovative treatments for chronic pain, today...

Apr 03, 2013, 07:00 ET

Collegium Pharmaceutical Names Douglas Carlson to Vice President of Business Development

 Collegium Pharmaceutical, Inc., a specialty pharmaceutical company focused on the development of innovative treatments for chronic pain, has...

Feb 28, 2013, 07:00 ET

Collegium Pharmaceutical's CEO to Present at the Cowen & Company 33rd Annual Health Care Conference in Boston on March 6, 2013

 Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, today announced that the company's President and CEO, Michael Heffernan,...

Feb 12, 2013, 07:00 ET

Collegium Pharmaceutical Inc. Announces Notice of Allowance for U.S. Patent Covering Oxycodone DETERx®, a Tamper-Resistant, Extended-Release Opioid Product

 Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, today announced that it has received Notice of Allowance from the U.S....

Jan 17, 2013, 07:00 ET

Collegium Pharmaceutical Announces Relocation to Massachusetts

 Collegium Pharmaceutical, Inc., a specialty pharmaceutical company focused on the development of innovative treatments for chronic pain, today...

Nov 27, 2012, 07:00 ET

Collegium Pharmaceutical to Present at Piper Jaffray's 24th Annual Healthcare Conference

 Collegium Pharmaceutical, Inc., a specialty pharmaceutical company focused on the development of innovative treatments for chronic...

Oct 19, 2012, 07:00 ET

Collegium Announces Poster Presentation for Oxycodone DETERx®, a Tamper-Resistant, Extended-Release Opioid at 2012 American Association of Pharmaceutical Scientists Annual Meeting

 Collegium Pharmaceutical, Inc., a specialty pharmaceutical company focused on the development of innovative treatments for chronic pain, today...

Organizations in the News

The organizations with the most activity in PR Newswire's News Room

ReportBuyer
Research and Markets
Investor-Edge